Effects of Bovine Lactoferrin on the Maintenance of Respiratory and Systemic Physical Conditions in Healthy Adults—A Randomized, Double-Blind, Placebo-Controlled Trial
Nutrients · 2023
DOI: 10.3390/nu15183959 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2023. Verfasst von Hirotsugu Oda und 8 weiteren Autor:innen. Beteiligte Einrichtung: Innovative Research Institute, R&D Division, Morinaga Milk Industry Co., Ltd., 5-1-83, Higashihara, Zama 252-8583, Japan. Hauptthemen laut MEDLINE: Lactoferrin. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Morinaga Milk Industry Co., Ltd..
Abstract (Originalsprache)
Objectives
We investigated the effects of bovine lactoferrin (LF) on the maintenance of the respiratory and systemic physical conditions.
Methods
A randomized, double-blind, placebo-controlled trial was conducted. Healthy adults at Kyushu University of Health and Welfare ingested a placebo or bovine LF (200 mg/day) for 12 weeks. The primary endpoints were the total respiratory and systemic symptom scores. The secondary endpoint was the activity of plasmacytoid dendritic cells (pDCs) in peripheral blood.
Results
A total of 157 subjects were randomized (placebo, n = 79; LF, n = 78), of whom, 12 dropped out. The remaining 145 participants were included in the full analysis set (placebo group, n = 77; LF group, n = 68). The total scores for respiratory and systemic symptoms during the intervention were significantly lower in the LF group than in the placebo group. The expression of CD86 and HLA-DR on pDCs was significantly higher in the LF group than in the placebo group at week 12. Adverse events were comparable between the groups, and no adverse drug reactions were observed.
Conclusions
These results suggest that orally ingested LF supports the normal immune system via maintaining pDC activity, and maintains respiratory and systemic physical conditions in healthy adults.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Innovative Research Institute, R&D Division, Morinaga Milk Industry Co., Ltd., 5-1-83, Higashihara, Zama 252-8583, Japan.
- International BtoB Business Department, International Division, Morinaga Milk Industry Co., Ltd., 5-33-1, Shiba, Minato 108-8384, Japan.
- Department of Biochemistry, Graduate School of Clinical Pharmacy, Kyushu University of Health and Welfare, 1714-1, Yoshino, Nobeoka 882-8508, Japan.
- School of Pharmaceutical Sciences, Kyushu University of Health and Welfare, 1714-1, Yoshino, Nobeoka 882-8508, Japan.
Förderung
- Morinaga Milk Industry Co., Ltd.
Zitieren
APA
Oda, H., Kubo, S., Tada, A., Yago, T., Sugita, C., Yoshida, H., Toida, T., Tanaka, M., & Kurokawa, M. (2023). Effects of Bovine Lactoferrin on the Maintenance of Respiratory and Systemic Physical Conditions in Healthy Adults—A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. https://doi.org/10.3390/nu15183959
Vancouver
Oda H, Kubo S, Tada A, Yago T, Sugita C, Yoshida H, et al. Effects of Bovine Lactoferrin on the Maintenance of Respiratory and Systemic Physical Conditions in Healthy Adults—A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2023. doi:10.3390/nu15183959
BibTeX
@article{Oda2023,
author = {Oda, Hirotsugu and Kubo, Shutaro and Tada, Asuka and Yago, Takumi and Sugita, Chihiro and Yoshida, Hiroki and Toida, Tatsunori and Tanaka, Miyuki and Kurokawa, Masahiko},
title = {Effects of Bovine Lactoferrin on the Maintenance of Respiratory and Systemic Physical Conditions in Healthy Adults—A Randomized, Double-Blind, Placebo-Controlled Trial},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15183959}
}
EUVIMED